The Development: China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The Guidelines provide a comprehensive framework ...
Only 5% of rare diseases have treatments, but approximately half have patient advocacy organizations; these groups have the potential to play major roles in positively influencing research and ...
After an extensive process of consultation, the Indian Patent Office recently finalised guidelines for examination of patent applications claiming pharmaceutical inventions. These industry specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results